The next stage of chronic care management and value-based insurance design for the continuing onslaught of high-priced specialty drugs, including PCSK9 inhibitors.
Patrick Dunham
Advertisement
Articles by Patrick Dunham
Advertisement
Latest Updated Articles
- Top ways to tap value from specialty drugs for chronic care
September 9th 2015
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Payers lean on step therapy, formulary exclusions as IRA reshapes Part D benefit design
2
1,700 sites closed, 77,000 fewer children received PEPFAR-supported treatment after PEPFAR disruption | IAS 2026
3
Redemplo cuts triglycerides, pancreatitis risk in severe hypertriglyceridemia
4
Step therapy requirements drive up time, costs in DME patients | ASRS 2026
5